DANIEL T MATTSON
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- BRIDGETON, MO
- NPI
- 1447237870
- Received
- $451,341 in 826 records, 2019 to 2025 ($451,051 general, $290 research)
- As principal investigator
- $26,878 of research payments to others in 17 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 89 | $48,264 |
| 2024 | General payment | 178 | $83,111 |
| 2024 | Research payment | 1 | $290 |
| 2023 | General payment | 176 | $87,301 |
| 2022 | General payment | 139 | $70,718 |
| 2021 | General payment | 95 | $67,840 |
| 2020 | General payment | 70 | $38,395 |
| 2019 | General payment | 78 | $55,419 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 141 | $265,655 |
| Honoraria | 47 | $109,545 |
| Travel and Lodging | 129 | $28,886 |
| Consulting Fee | 18 | $24,708 |
| Food and Beverage | 485 | $22,213 |
| Research payment | 1 | $290 |
| Education | 5 | $43 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-20 | SK Life Science, Inc. | $2,500 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2025 | |
| 2025-11-20 | SK Life Science, Inc. | $124 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $83 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-11-06 | SK Life Science, Inc. | $250 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2025 | |
| 2025-10-24 | UCB, Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Nayzilam Drug, Neurology | 2025 | |
| 2025-10-22 | JAZZ PHARMACEUTICALS INC. | $3,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-22 | JAZZ PHARMACEUTICALS INC. | $264 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-16 | Medtronic, Inc. | $125 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-16 | Medtronic, Inc. | $10 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-06 | JAZZ PHARMACEUTICALS INC. | $2,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-06 | JAZZ PHARMACEUTICALS INC. | $18 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-09-30 | JAZZ PHARMACEUTICALS INC. | $27 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-09-18 | Neurelis, Inc. | $898 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $136 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-03 | Neurelis, Inc. | $98 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-08-21 | UCB, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Nayzilam Drug, Neurology | 2025 | |
| 2025-08-21 | Neurelis, Inc. | $898 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-08-21 | UCB, Inc. | $168 | Travel and Lodging | Cash or cash equivalent | Nayzilam Drug, Neurology | 2025 | |
| 2025-08-15 | SK Life Science, Inc. | $150 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-31 | Neurelis, Inc. | $104 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-07-02 | SK Life Science, Inc. | $500 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2025 | |
| 2025-06-17 | SK Life Science, Inc. | $143 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-17 | SK Life Science, Inc. | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-03 | UCB, Inc. | $9 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-05-29 | Neurelis, Inc. | $1,908 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-05-29 | Neurelis, Inc. | $49 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-05-28 | SK Life Science, Inc. | $145 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-28 | SK Life Science, Inc. | $30 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-22 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-05-21 | Medtronic, Inc. | $190 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-05-21 | Medtronic, Inc. | $14 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-05-19 | Neurelis, Inc. | $25 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-05-08 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-05-06 | Neurelis, Inc. | $1,193 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-05-01 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-04-30 | JAZZ PHARMACEUTICALS INC. | $268 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-30 | JAZZ PHARMACEUTICALS INC. | $9 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-28 | JAZZ PHARMACEUTICALS INC. | $3,920 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-24 | JAZZ PHARMACEUTICALS INC. | $195 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-24 | JAZZ PHARMACEUTICALS INC. | $117 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-24 | JAZZ PHARMACEUTICALS INC. | $19 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-24 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-04-23 | JAZZ PHARMACEUTICALS INC. | $63 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-17 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-04-10 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-04-03 | Neurelis, Inc. | $1,193 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-04-03 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-02 | JAZZ PHARMACEUTICALS INC. | $4,410 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-04-02 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-03-27 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-03-20 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-03-19 | JAZZ PHARMACEUTICALS INC. | $3,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-19 | Medtronic, Inc. | $87 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-03-18 | Medtronic, Inc. | $38 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-03-17 | JAZZ PHARMACEUTICALS INC. | $264 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-14 | Neurelis, Inc. | $2,862 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-03-14 | SK Life Science, Inc. | $500 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2025 | |
| 2025-03-14 | Neurelis, Inc. | $221 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-03-13 | JAZZ PHARMACEUTICALS INC. | $19 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-13 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-03-08 | JAZZ PHARMACEUTICALS INC. | $124 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-08 | JAZZ PHARMACEUTICALS INC. | $59 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-08 | JAZZ PHARMACEUTICALS INC. | $49 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-08 | JAZZ PHARMACEUTICALS INC. | $24 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-08 | JAZZ PHARMACEUTICALS INC. | $24 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-07 | JAZZ PHARMACEUTICALS INC. | $398 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-07 | JAZZ PHARMACEUTICALS INC. | $298 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-07 | JAZZ PHARMACEUTICALS INC. | $128 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-03-06 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-02-27 | Neurelis, Inc. | $204 | Travel and Lodging | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-02-27 | Neurelis, Inc. | $60 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-02-27 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-02-20 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-02-19 | Neurelis, Inc. | $161 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-02-18 | JAZZ PHARMACEUTICALS INC. | $18 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-02-12 | JAZZ PHARMACEUTICALS INC. | $2,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-02-12 | JAZZ PHARMACEUTICALS INC. | $2,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-02-12 | Medtronic, Inc. | $148 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-02-12 | JAZZ PHARMACEUTICALS INC. | $23 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-02-11 | JAZZ PHARMACEUTICALS INC. | $28 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-02-06 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-30 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-29 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-01-23 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-14 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-09 | UCB, Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Nayzilam Drug, Neurology | 2025 | |
| 2025-01-09 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-01-08 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2024-12-19 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-12-16 | JAZZ PHARMACEUTICALS INC. | $2,940 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-12-16 | JAZZ PHARMACEUTICALS INC. | $253 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-12-12 | Neurelis, Inc. | $42 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-12-12 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-12-11 | JAZZ PHARMACEUTICALS INC. | $21 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-12-06 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2024 | |
| 2024-12-05 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-12-04 | Medtronic, Inc. | $86 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2024 | |
| 2024-12-04 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-11-27 | Neurelis, Inc. | $1,608 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-11-26 | UCB, Inc. | $6 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2024 | |
| 2024-11-21 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $3,500 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $613 | Travel and Lodging | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $284 | Travel and Lodging | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $148 | Travel and Lodging | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $119 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-20 | SK Life Science, Inc. | $48 | Food and Beverage | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-14 | Neurelis, Inc. | $124 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-11-14 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug, IMMUNOLOGY | 2024 | |
| 2024-11-14 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-11-13 | SK Life Science, Inc. | $2,500 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-13 | SK Life Science, Inc. | $125 | Travel and Lodging | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-13 | SK Life Science, Inc. | $81 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-11-12 | JAZZ PHARMACEUTICALS INC. | $1,470 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-11-07 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-31 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-25 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-10-24 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-22 | Medtronic, Inc. | $290 | Research payment | Cash or cash equivalent | 2024 | ||
| 2024-10-22 | JAZZ PHARMACEUTICALS INC. | $71 | Travel and Lodging | In-kind items and services | XYWAV Drug, NEUROLOGY | 2024 | |
| 2024-10-18 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-10-17 | JAZZ PHARMACEUTICALS INC. | $5,337 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XYWAV Drug, NEUROLOGY | 2024 | |
| 2024-10-16 | SK Life Science, Inc. | $3,000 | Honoraria | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-10-16 | SK Life Science, Inc. | $339 | Travel and Lodging | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-10-16 | SK Life Science, Inc. | $168 | Travel and Lodging | Cash or cash equivalent | XCOPRI Drug, Neurology | 2024 | |
| 2024-10-16 | SK Life Science, Inc. | $107 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-10-16 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-10-16 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-11 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-10-10 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-08 | Medtronic, Inc. | $114 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2024 | |
| 2024-10-07 | JAZZ PHARMACEUTICALS INC. | $2,940 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-10-03 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-10-02 | UCB, Inc. | $9 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-09-30 | JAZZ PHARMACEUTICALS INC. | $25 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-09-27 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-16 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-09-13 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-12 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-09-11 | CATALYST PHARMACEUTICALS, INC. | $16 | Education | Cash or cash equivalent | FYCOMPA Drug, NEUROLOGY | 2024 | |
| 2024-09-06 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-09-05 | Neurelis, Inc. | $2,412 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-09-05 | Neurelis, Inc. | $162 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-30 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-08-23 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-08-23 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | Neurelis, Inc. | $266 | Travel and Lodging | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-21 | Neurelis, Inc. | $96 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-16 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-08-09 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-08-08 | Neurelis, Inc. | $2,412 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-06 | UCB, Inc. | $98 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2024 | |
| 2024-08-02 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-08-02 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-08-01 | Neurelis, Inc. | $2,412 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-01 | Neurelis, Inc. | $158 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-01 | Neurelis, Inc. | $154 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-08-01 | SK Life Science, Inc. | $122 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-29 | JAZZ PHARMACEUTICALS INC. | $3,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-07-26 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-07-26 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-07-25 | Neurelis, Inc. | $23 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-07-23 | UCB, Inc. | $5 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2024 | |
| 2024-07-22 | JAZZ PHARMACEUTICALS INC. | $146 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-07-19 | JAZZ PHARMACEUTICALS INC. | $282 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-07-19 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-19 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-19 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-07-19 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-07-18 | Neurelis, Inc. | $122 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-07-18 | JAZZ PHARMACEUTICALS INC. | $98 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-07-15 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-12 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-09 | JAZZ PHARMACEUTICALS INC. | $122 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-06-28 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-06-28 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-06-28 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-06-26 | JAZZ PHARMACEUTICALS INC. | $166 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-06-24 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2024 | |
| 2024-06-21 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-06-21 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-17 | JAZZ PHARMACEUTICALS INC. | $3,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-06-14 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-06-14 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-13 | UCB, Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Nayzilam Drug, Neurology | 2024 | |
| 2024-06-13 | UCB, Inc. | $12 | Travel and Lodging | Cash or cash equivalent | Nayzilam Drug, Neurology | 2024 | |
| 2024-06-08 | JAZZ PHARMACEUTICALS INC. | $141 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-05-31 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-05-31 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-05-30 | Neurelis, Inc. | $2,412 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-30 | Neurelis, Inc. | $2,412 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-30 | Neurelis, Inc. | $43 | Travel and Lodging | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2024 | |
| 2024-05-30 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-05-22 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2024 | |
| 2024-05-16 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-05-16 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2024 | |
| 2024-05-15 | JAZZ PHARMACEUTICALS INC. | $119 | Travel and Lodging | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2024 | |
| 2024-05-13 | JAZZ PHARMACEUTICALS INC. | $2,940 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EPIDIOLEX Drug, NEUROLOGY | 2024 |
The latest 200 records of 826.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-08-12 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $1,323 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-07-24 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $1,000 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-06-13 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $4,000 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-05-28 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $1,764 | A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-05-22 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $90 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-05-22 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $895 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-02-06 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $1,332 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-01-30 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $11,724 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2025-01-09 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $23 | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2025 |
| 2024-12-31 | ABBVIE INC. | Clinical Research Professionals | $434 | A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate the Safety, Tolerability, and Pharmacodynamics of CVL-8 | 2024 |
| 2024-11-19 | ABBVIE INC. | CLINICAL TRIALS INC | $82 | An Open-label Extension Trial of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-10-29 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $30 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-10-29 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $4,000 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-09-19 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $58 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-09-05 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $30 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-09-05 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $58 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
| 2024-09-05 | ABBVIE INC. | CLINICAL RESEARCH PROFESSIONALS LLC | $30 | A Trial of the Efficacy and Safety of?CVL-865?as Adjunctive Therapy in the Treatment of Focal Onset Seizures | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bridgeton, MO, county St. Louis County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Bridgeton, MO | County St. Louis County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 11,369 | 995,569 | 6,191,814 |
| Population, 2020 census P1 | 11,445 | 1,004,125 | 6,154,913 |
| Median age B01002 | 40.9 | 40.3 | 39.0 |
| Under 18 B01001 | 21.8% | 22.0% | 22.3% |
| 65 and over B01001 | 21.5% | 19.1% | 17.9% |
| Households B11001 | 4,747 | 413,849 | 2,508,227 |
| Foreign born B05002 | 13.9% | 8.4% | 4.5% |
| Median household income B19013 | $72,005 | $82,936 | $70,702 |
| Median family income B19113 | $83,153 | $110,950 | $91,360 |
| Per capita income B19301 | $39,809 | $51,977 | $39,695 |
| Poverty rate B17001 | 11.5% | 9.8% | 12.6% |
| Unemployment rate B23025 | 3.2% | 4.3% | 4.0% |
| Civilian labor force B23025 | 5,774 | 521,387 | 3,120,639 |
| Mean commute (minutes) B08013 | 21.2 | 23.1 | 23.5 |
| Bachelor's degree or higher B15003 | 36.0% | 47.4% | 32.4% |
| Housing units B25001 | 5,066 | 446,192 | 2,825,287 |
| Owner-occupied B25003 | 63.1% | 69.2% | 68.1% |
| Renters B25003 | 36.9% | 30.8% | 31.9% |
| Median home value B25077 | $237,700 | $276,800 | $230,300 |
| Median gross rent B25064 | $1,172 | $1,209 | $1,033 |
| White, not Hispanic B03002 | 55.8% | 61.4% | 76.3% |
| Black B03002 | 23.7% | 24.0% | 10.9% |
| Hispanic or Latino B03002 | 13.8% | 3.9% | 5.2% |
| Asian B03002 | 2.7% | 4.9% | 2.1% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bridgeton, MO.
Comments